CSE:AGN - Post Discussion
Post by
waves1 on Feb 17, 2023 2:22pm
AGN CEO on the latest DMT study update
AGN CEO on Proactive discussing the latest update on its Phase I clinical study of DMT for stroke: https://www.youtube.com/watch?v=MQbGcjIt1dI&ab_channel=paidpromotionalmessages
AGN will be moving the study forward with an escalated dose after observing no safety or tolerability issues
Be the first to comment on this post